The androgen receptor CAG repeat: A modifier of carcinogenesis?

Molecular and Cellular Endocrinology

Volumn 193, Issue 1-2, 2002, Pages 109-120

  Ferro, Paola ^a   Catalano, Maria G ^b   Dell'Eva, Raffaella ^a   Fortunati, Nicoletta ^b   Pfeffer, Ulrich ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Androgen receptor; CAG repeat; Colon cancer; Kennedy's disease; Low penetrance susceptibility gene; Microsatellite instability; Somatic mutation

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; BRCA1 PROTEIN; ISOPROTEIN; POLYGLUTAMINE; PROTEIN P160; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

AMINO TERMINAL SEQUENCE; BREAST CANCER; CANCER GROWTH; CANCER RECURRENCE; CANCER RISK; CARCINOGENESIS; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; CONFERENCE PAPER; ENDOMETRIUM CANCER; EXON; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; KENNEDY DISEASE; MALE; MICROSATELLITE INSTABILITY; MITOGENESIS; NERVE CELL DEGENERATION; NUCLEOTIDE REPEAT; ONCOGENE; ONSET AGE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPINAL MUSCULAR ATROPHY; TRANSACTIVATION; WESTERN BLOTTING; BREAST TUMOR; COLON TUMOR; ENDOMETRIUM TUMOR; GENETICS; NEOPLASM; PHYSIOLOGY; PROSTATE TUMOR; REVIEW; TRINUCLEOTIDE REPEAT;

BREAST NEOPLASMS; COLONIC NEOPLASMS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MALE; NEOPLASMS; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TRINUCLEOTIDE REPEATS;

EID: 0037205905     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00104-1     Document Type: Conference Paper

References (138)

1. Low frequency of microsatellite instability in hereditary prostate cancer
2. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription
3. The androgen receptor (AR) in syndromes of androgen insensitivity and in prostate cancer
4. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines
5. Analysis of the CAG repeat region of the androgen receptor gene in a kindred with X-linked spinal and bulbar muscular atrophy
6. Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2)
7. The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1
8. Role of the androgen receptor in human breast cancer
9. Polymorphisms in the vitamin D receptor gene and the androgen receptor gene and the risk of benign prostatic hyperplasia
10. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk
11. Altered expression of androgen-receptor isoforms in human colon-cancer tissues
12. Inhibition of endometrial carcinoma cell cultures by a synthetic androgen
13. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function
14. Reduced androgen receptor gene expression with first exon CAG repeat expansion
15. Prostate cancer and the androgen receptor
16. (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population
17. The size of the CAG repeat in exon 1 of the androgen receptor gene shows no significant relationship to impaired spermatogenesis in an infertile Caucasoid sample of German origin
18. Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction
19. Androgens and fetal growth
20. Linkage between male infertility and trinucleotide repeat expansion in the androgen-receptor gene
21. Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival
22. Genomic instability of microsatellite repeats in prostate cancer: relationship to clinicopathological variables
23. Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis
24. Cell death in polyglutamine diseases
25. Somatic alterations of the androgen receptor CAG repeat in human colon delineate a novel mutation pathway
26. Functional activities of the A and B forms of the human androgen receptor in response to androgen receptor agonists and antagonists
27. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer
28. The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia
29. CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in US physicians
30. The androgen receptor exon 1 trinucleotide repeat does not act as a modifier of the age of presentation in breast cancer
31. Update of the androgen receptor gene mutations database
32. The mutation properties of spinal and bulbar muscular atrophy disease alleles
33. Postmenopausal hormone use and risk for colorectal cancer and adenoma
34. Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids
35. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer
36. Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset
37. The effect of sex hormones and tamoxifen on the growth of human gastric and colorectal cancer cell lines
38. SMAD3 represses androgen receptor-mediated transcription
39. Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain, J. Biol. Chem. 274, 37219-37225.
40. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor
41. Isolation and characterization of ARA160 as the first androgen receptor N-terminal-associated coactivator in human prostate cells
42. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China
43. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators
44. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length
45. Effects of androgen manipulations on chemically induced colonic tumours and on macroscopically normal colonic mucosa in male Sprague-Dawley rats
46. The role of the androgen receptor in the development and progression of prostate cancer
47. Androgen receptor gene polymorphism and prostate zonal volumes in Australian and Chinese men
48. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers
49. From transforming growth factor-beta signaling to androgen action: Identification of Smad3 as an androgen receptor coregulator in prostate cancer cells
50. Correlation of androgen receptors with histological differentiation in human endometrial carcinomas
51. Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease?
52. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice
53. Androgen receptor gene and hormonal therapy failure of prostate cancer
54. Androgen receptor YAC transgenic mice carrying CAG 45 alleles show trinucleotide repeat instability
55. The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer
56. Single sperm analysis of the trinucleotide repeats in the Huntington's disease gene: quantification of the mutation frequency spectrum
57. The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series
58. Nonneural nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy
59. Male breast cancer and the androgen receptor gene
60. Androgen receptor gene mutation in male breast cancer
61. Transcriptional interferences between normal or mutant androgen receptors and the activator protein 1-dissection of the androgen receptor functional domains
62. Characterization of androgen receptors in a well-differentiated endometrial adenocarcinoma cell line (Ishikawa)
63. Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor alpha
64. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability
65. Cytosolic and nuclear androgen receptors in colorectal adenomas
66. Gender differences in colorectal polyps and tumors
67. Status of sex steroid hormone receptors in large bowel cancer
68. Sex steroid and 1,25-dihydroxyvitamin D3 receptors in human colorectal adenocarcinoma and normal mucosa
69. Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy
70. Androgen receptor gene CAG trinucleotide repeats in anovulatory infertility and polycystic ovaries
71. Trinucleotide (CAG) repeat polymorphisms in the androgen receptor gene: molecular markers of risk for male infertility
72. Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): correlation with adenoma growth
73. Hypospadias and the androgen receptor gene: mutation screening and CAG repeat length analysis
74. Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression
75. Clinical aspects of CAG repeat diseases
76. Undermasculinized genitalia in a boy with an abnormally expanded CAG repeat length in the androgen receptor gene bigstar
77. CAG-polyglutamine-repeat mutations: independence from gene context
78. Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor
79. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer
80. Larger trinucleotide repeat size in the androgen receptor gene of infertile men with extremely severe oligozoospermia
81. Toward an understanding of polyglutamine neurodegeneration
82. Prevention by chemopreventive agents of azoxymethane-induced foci of aberrant crypts in rat colon
83. Microsatellite instability of dinucleotide tandem repeat sequences is higher than trinucleotide, tetranucleotide and pentanucleotide repeat sequences in prostate cancer
84. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases
85. Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and in MCF-7 cells
86. Alternative splicing of the estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines
87. The coding region of the human DLX6 gene contains a polymorphic CAG/CCG repeat
88. The androgen receptor gene GGN microsatellite and prostate cancer risk
89. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten- 17-one, and ellagic acid individually and in combination
90. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat
91. Modification of brca1- and brca2-associated breast cancer risk by aib1 genotype and reproductive history
92. CAG repeat length of the androgen receptor gene in Japanese males with cryptorchidism
93. The expansion of the CAG repeat in exon 1 of the human androgen receptor gene is associated with uterine endometrial carcinoma
94. Inactivation of the human androgen receptor gene is associated with CpG hypermethylation in uterine endometrial cancer
95. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
96. Dehydroepiandrosterone stimulates proliferation and gene expression in MCF-7 cells after conversion to estradiol
97. Microsatellite mutation (CAG24→18) in the androgen receptor gene in human prostate cancer
98. Genomic structure and mutation screening of the E2F4 gene in human tumors
99. X-linked recessive bulbospinal neuronopathy: clinical phenotypes and CAG repeat size in androgen receptor gene
100. Sex differences in the incidence of colorectal cancer: an exploration of oestrogen and progesterone receptors
101. Nuclear inclusions in glutamine repeat disorders: are they pernicious, coincidental, or beneficial?
102. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer
103. Glucocorticoid receptor inhibits transforming growth factor-beta signaling by directly targeting the transcriptional activation function of Smad3
104. Somatic stability of the expanded CAG trinucleotide repeat in X-linked spinal and bulbar muscular atrophy
105. Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years
106. Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer
107. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk
108. Effect of steroid hormones on human colorectal adenocarcinoma xenografts, of known steroid-receptor status, in nude mice
109. Microsatellite instability and other molecular abnormalities in human prostate cancer
110. Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor
111. Tissue-specific somatic mosaicism in spinal and bulbar muscular atrophy is dependent on CAG-repeat length and androgen receptor-gene expression level
112. Gonadotropins stimulate growth of MCF-7 human breast cancer cells by promoting intracellular conversion of adrenal androgens to estrogens
113. Microsatellite instability in adenocarcinoma of the prostate
114. Characterization and expression of a cDNA encoding the human androgen receptor
115. Microsatellite instability in prostate cancer
116. Inverse correlation between sperm concentration and number of androgen receptor CAG repeats in normal men
117. Molecular study of sex steroid receptor gene expression in human colon and in colorectal carcinomas
118. Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50
119. Microsatellite instability in human prostate cancer
120. Microsatellite instability in latent prostate cancers
121. Genetic alterations of androgen receptor gene in Japanese human prostate cancer
122. Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse
123. A and B forms of the androgen receptor are present in human genital skin fibroblasts
124. A and B forms of the androgen receptor are expressed in a variety of human tissues
125. Microsatellite instability and alteration of E2F-4 gene in adenosquamous and squamous cell carcinomas of the stomach
126. High frequency microsatellite instability in mucinous adenocarcinoma of the prostate
127. Susceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen loci
128. Genetic determinants of serum prostate-specific antigen levels in healthy men from a multiethnic cohort
129. CAG repeat length in the androgen receptor gene is enhanced in patients with idiopathic azoospermia
130. Cell cycle arrest enhances the in vitro cellular toxicity of the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch
131. Trinucleotide repeats are clustered in regulatory genes in Saccharomyces cerevisiae
132. Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer
133. Studying human mutations by sperm typing: instability of CAG trinucleotide repeats in the human androgen receptor gene
134. Smad3 mutant mice develop metastatic colorectal cancer
135. Complete testicular feminization caused by an amino-terminal truncation of the androgen receptor with downstream initiation